Isolation of equine herpesvirus-1 mutants in the presence of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine: demonstration of resistance in vitro and in vivo
- 31 July 1991
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 16 (1) , 29-39
- https://doi.org/10.1016/0166-3542(91)90056-w
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effective chemotherapy of equine herpesvirus 1 by phosphonylmethoxyalkyl derivatives of adenine demonstrated in a novel murine model for the diseaseAntimicrobial Agents and Chemotherapy, 1990
- The Pathogenesis of Equine Herpesvirus Type 1 in the Mouse: A New Model for Studying Host Responses to the InfectionJournal of General Virology, 1990
- Analysis of the Bovine Herpesvirus Type 1 Thymidine Kinase (TK) Gene from Wild-type Virus and TK-deficient MutantsJournal of General Virology, 1989
- Evolution of the herpes thymidine kinase: identification and comparison of the equine herpesvirus 1 thymidine kinase gene reveals similarity to a cell-encoded thymidylate kinaseNucleic Acids Research, 1988
- Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidinesAntiviral Research, 1987
- Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell cultureAntimicrobial Agents and Chemotherapy, 1987
- A novel selective broad-spectrum anti-DNA virus agentNature, 1986
- A virus-specific thymidine kinase in BHK21 cells infected with herpes simplex virusVirology, 1967